BIIB021

• Background:

  Potent HSP90 inhibitor (IC50 = 30 nM HER-2 degradation) .1 It inhibited the proliferation of MCF7 and BT474 breast cancer cell lines (IC50 = 100 nM for each) . BIIB021 has shown efficacy as a therapeutic in multiple cancer models.2-5

• Conjugation:

  Unconjugated

• Buffer:

  White solid

• Storage Conditions:

  -20°C